Therapeutic effects of chimeric antigen receptor T cells (CAR-T) on relapse/refractory diffuse large B-cell lymphoma (R/R DLBCL): a meta-analysis.
Cao HH, Wang LL, Geng CK, Mao WW, Yang LL, Ma Y, He M, Zhang R, Zhou YY, Liu LQ, Hu XJ, Yu JX, Yang L, Shen XF, Yin LF, Gu XZ, Shen ZL.
Cao HH, et al. Among authors: geng ck.
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4921-4930. doi: 10.26355/eurrev_202005_21181.
Eur Rev Med Pharmacol Sci. 2020.
PMID: 32432755
Free article.